5 Aug

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

Following Royalty Pharma’s ground-breaking IPO, Healthcare Royalty’s offering is further proof of the maturation of a market that is expanding opportunities for monetising innovations in the life sciences

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth